Quince Therapeutics Inc. (QNCX) Live Share Price, Invest From India

Quince Therapeutics Inc. Stock Performance

as on July 30, 2026 at 6:59 am IST

Day's Low
Day's High
$18.96
Day's Price Range
$22.15
$21.85
13.23%
Downside
1.37%
Upside
52 Week's Low
52 Week's High
$15.10
52-Week Price Range
$909.98
$21.85
30.89%
Downside
4064.67%
Upside

Quince Therapeutics Inc. share price movements today

Previous Close: $19.37
Open: $18.96
Volume: 336.3K
Day's Low - High: $18.96 - $22.15
52 Week Low - High: $15.10 - $909.98

Quince Therapeutics Inc. Historical Returns

1 Month Return: + 6.49 %
3 Month Return: -26.07 %
1 Year Return: -94.13 %
3 Year Return: -91.79 %
5 Year Return: 0 %

Quince Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Quince Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$17.5M

EPS (TTM)

-1.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-48.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-192.90%

Quince Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quince Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Quince Therapeutics Inc.	SELL	$17.5M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.0B	541.97%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$121.6B	143.27%	28.33	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$69.9B	20.98%	16.03	29.65%	0.5499999999999999%

Stock Returns calculator for Quince Therapeutics Inc. Stock including INR - Dollar returns

The Quince Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Quince Therapeutics Inc. investment value today

Current value as on today

₹7,270

Returns

-₹92,730

(-92.73%)

Returns from Quince Therapeutics Inc. Stock

-₹93,379 (-93.38%)

Dollar Impact

₹649 (+0.65%)

Analyst Recommendation on Quince Therapeutics Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Quince Therapeutics Inc.. Average target price of $83.33

Quince Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Quince Therapeutics Inc..

What analysts predicted

73.78%UPSIDE

Target Price

$83.33

Current Price

$21.85

Analyzed by

6 Analysts

Target

$83.33

Quince Therapeutics Inc. target price $83.33, a slight upside of 73.78% compared to current price of $21.85. According to 6 analysts rating.

Indian Investors' Interest in Quince Therapeutics Inc. Stock

Search interest for Quince Therapeutics Inc. Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 30, 2026 to July 30, 2026

Change:-3% versus previous 30 day period

Quince Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	0	-	-	0	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	0	-	0
Operating Income	-8	-11	-28	-5	-10	-14	-9	-13	-16	-11
EBITDA	-	-8	-8	-8	-12	-12	-15	-11	-	30
Interest Expense	-	0	-	-	2	-	-	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-11	-27	-5	-12	-14	-15	-13	-36	30
Income Tax Expense	-	0	0	0	0	0	0	0	-	-5
Net Income	-8	-11	-27	-5	-12	-15	-16	-13	-39	35
Net Profit Margin	0.00%	-30969.44%	0.00%	0.00%	-7415.48%	0.00%	0.00%	0.00%	0.00%	0.00%

Quince Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	-12	-39	-78	-90	-52	-34	-57	-50
EBITDA	-12	-38	-78	-89	-50	-26	-35	-80
Interest Expense	0	2	2	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-12	-36	-76	-89	-51	-31	-56	-80
Income Tax Expense	0	0	2	0	0	0	0	3
Net Income	-12	-36	-76	-89	-51	-31	-56	-83
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Quince Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-11	-27	-5	-12	-15	-16	-13	-39	35
Operating Cash Flow	-8	-8	-7	-7	-9	-11	-9	-10	-7
Investing Cash Flow	8	-4	7	10	10	6	-1	-	12
Financing Cash Flow	0	0	-5	-	0	14	1	2	9
Change in Cash	1	-13	-5	3	1	9	-10	0	12

Quince Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-36	-76	-89	-51	-31	-56	-83
Operating Cash Flow	-11	-33	-50	-62	-44	-18	-31	-41
Investing Cash Flow	-46	-17	-52	58	18	-5	21	23
Financing Cash Flow	75	77	118	6	0	0	-4	17
Change in Cash	17	26	15	2	-25	-23	-14	0

Global Institutional Holdings in Quince Therapeutics Inc.

Funds	Holdings
Vanguard Group Inc	1.07%
Nantahala Capital Management, LLC	1.64%
Shay Capital LLC	0.91%
StemPoint Capital LP	0.45%
BlackRock Inc	0.24%

See all

Insights on Quince Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 396.7% return, outperforming this stock by 490.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.1% return, outperforming this stock by 706.9%
NEGATIVE IMPACT
Price Dip
In the last 1 year, QNCX stock has moved down by -94.1%

About Quince Therapeutics Inc.

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consist of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Organisation	Quince Therapeutics Inc.
Headquarters	611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Dr. Dirk Thye M.D.
E-voting on shares	Click here to vote

Key Management of Quince Therapeutics Inc.

Name	Title
Mr. Brendan Hannah M.B.A.	Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer
Dr. Guenter R. Janhofer M.D., Ph.D.	Chief Scientific Officer
Dr. Brigette Roberts M.D.	Chief Corporate Affairs Officer & Director
Dr. Dirk Thye M.D.	CEO, Chief Medical Officer & Director
Dr. Charles S. Ryan J.D., Ph.D.	President

FAQs

What is Quince Therapeutics Inc. share price today?

Quince Therapeutics Inc. share price today is $21.85 as on July 30, 2026 at 1:29 am IST at the close of the market. Quince Therapeutics Inc. share today touched a day high of $22.15 and a low of $18.96.

What is the 52 week high and 52 week low for Quince Therapeutics Inc. share?

Quince Therapeutics Inc. share touched a 52 week high of $909.98 on January 1, 1970 and a 52 week low of $15.10 on January 1, 1970. Quince Therapeutics Inc. stock price today i.e. July 30, 2026 at 1:29 am IST is closed at $21.85,which is 97.60% down from its 52 week high and 44.70% up from its 52 week low.

What is Quince Therapeutics Inc.'s market capitalisation today?

Quince Therapeutics Inc. market capitalisation is $0.00T as on July 30, 2026 at 1:29 am IST.

How to invest in Quince Therapeutics Inc. Stock (QNCX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Quince Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quince Therapeutics Inc. Shares that will get you 0.0686 shares as per Quince Therapeutics Inc. share price of $21.85 per share as on July 30, 2026 at 1:29 am IST.

What is the minimum amount required to buy Quince Therapeutics Inc. Stock (QNCX) from India?

Indian investors can start investing in Quince Therapeutics Inc. (QNCX) shares with as little as ₹95.6475 or $1 (as of July 30, 2026 at 7:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.47 in Quince Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 30, 2026 at 7:39 am IST). Based on Quince Therapeutics Inc. share’s latest price of $21.85 as on July 30, 2026 at 1:29 am IST, you will get 0.4577 shares of Quince Therapeutics Inc.. Learn more about fractional shares .